Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Zetia

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Zetia was produced by Merck & Co. and Bayer.

Merck profit slides as generics continue to bite

Merck profit slides as generics continue to bite HIV drug Isentress (raltegravir) climbed 5 per cent to $410m, holding up fairly well despite increased competition from the likes of Gilead Sciences' elvitegravir, while sales of cholesterol drugs Zetia (ezetimibe) ... and Vytorin (ezetimibe and

Merck & Co wins green light in US for Zetia-Lipitor combo

Merck & Co wins green light in US for Zetia-Lipitor combo Vytorin extension wins FDA approval. Merck &Co has been awarded marketing approval for Liptruzet, a new combination cholesterol treatment based on Zetia and generic atorvastatin. ... The new once-daily drug is a line extension to Merck's Vytorin product,

Merck & Co's sugammadex delayed in US

Merck & Co's sugammadex delayed in US insomnia drug suvorexant, ovarian cancer treatment vintafolide, and its combination of Zetia (ezetimibe) and atorvastatin for high cholesterol.

Merck forges on with Vytorin trial after safety review

Merck forges on with Vytorin trial after safety review The debate has dampened demand for Vytorin and also ezetimibe monotherapy Zetia, which has had its own problems including a study which suggested the drug increased atherosclerotic plaque volumes in peripheral

Former Amgen R&D head Perlmutter to lead research at Merck & Co

Former Amgen R&D head Perlmutter to lead research at Merck & Co It also pulled development of a combination cholesterol therapy based on Januvia (sitagliptin) and atorvastatin; abandoned another cholesterol drug based on Zetia (ezetimibe) and niacin; and suffered a regulatory setback when

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Cello Health

Cello Health are expert navigators, helping healthcare clients uncover hidden insights, explore scientific options and make difficult strategic choices...

Latest intelligence

Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...
Behaviour change through medical education: How can we turn aspiration into reality?
Practical, evidence-based insights into a CME process that aims to effect measurable behaviour change...

Infographics